PMM2-CDG, due to the impairment of enzyme phosphomannomutase2 (PMM2), is the most prevalent CDG with an incidence rate of 1 in 20,000 individuals [1–3]. The gene discussed is PMM2; the disease is congenital disorder of glycosylation.